NuMedii Revenue and Competitors
Estimated Revenue & Valuation
- NuMedii's estimated annual revenue is currently $930k per year.
- NuMedii's estimated revenue per employee is $155,000
Employee Data
- NuMedii has 6 Employees.
- NuMedii grew their employee count by 0% last year.
NuMedii's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO/Founder | Reveal Email/Phone |
2 | VP Research | Reveal Email/Phone |
NuMedii Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is NuMedii?
NuMedii discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies with a higher probability of therapeutic success. The Company’s proprietary and dynamic Big Data technology, developed in Atul Butte’s lab at Stanford University and licensed exclusively to NuMedii, consists of hundreds of millions of human, biological, pharmacological and clinical data points that the company has normalized and annotated. The company integrates these data with proprietary network-based algorithms to find both drug candidates and biomarkers predictive of efficacy for diseases.
keywords:N/AN/A
Total Funding
6
Number of Employees
$930k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.4M | 6 | 0% | N/A |
#2 | $0.1M | 6 | 0% | $9.8M |
#3 | $0.9M | 6 | -40% | N/A |
#4 | $0.9M | 6 | 0% | N/A |
#5 | $0.4M | 6 | -50% | N/A |